Abstract
The Supreme Court's recent decision in Association for Molecular Pathology v. Myriad Genetics ([ 1 ][1]) was widely regarded for its conclusion that patents could not be held over isolated DNA. However, Myriad maintains a confidential library of BRCA variants of undetermined significance (VUSs) ([ 2
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.